| European Case Law Identifier: | ECLI:EP:BA:2015:T001314.20151015 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 15 October 2015 | ||||||||
| Case number: | T 0013/14 | ||||||||
| Application number: | 08153777.1 | ||||||||
| IPC class: | A61K 31/496 A61P 25/18 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Agent for treatment of schizophrenia | ||||||||
| Applicant name: | Sumitomo Dainippon Pharma Co., Ltd. | ||||||||
| Opponent name: | - | ||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Double patenting (no) - Swiss-type claim and purpose-limited product claim (Article 54(5) EPC 2000) not the same subject-matter Remittal to the department of first instance (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t140013eu1.html
Date retrieved: 17 May 2021